Plunkett W - Search Results

1

Cell cycle-specific metabolism of arabinosyl nucleosides in K562 human leukemia cells.

Gandhi V, Plunkett W. Gandhi V, et al. Among authors: plunkett w. Cancer Chemother Pharmacol. 1992;31(1):11-7. doi: 10.1007/BF00695988. Cancer Chemother Pharmacol. 1992. PMID: 1458554

2

Treatment of core-binding-factor in acute myelogenous leukemia with fludarabine, cytarabine, and granulocyte colony-stimulating factor results in improved event-free survival.

Borthakur G, Kantarjian H, Wang X, Plunkett WK Jr, Gandhi VV, Faderl S, Garcia-Manero G, Ravandi F, Pierce S, Estey EH. Borthakur G, et al. Cancer. 2008 Dec 1;113(11):3181-5. doi: 10.1002/cncr.23927. Cancer. 2008. PMID: 18932257 Free PMC article. Clinical Trial.

3

Action of (E)-2'-deoxy-2'-(fluoromethylene)cytidine on DNA metabolism: incorporation, excision, and cellular response.

Zhou Y, Achanta G, Pelicano H, Gandhi V, Plunkett W, Huang P. Zhou Y, et al. Among authors: plunkett w. Mol Pharmacol. 2002 Jan;61(1):222-9. doi: 10.1124/mol.61.1.222. Mol Pharmacol. 2002. PMID: 11752224

4

Cellular and clinical pharmacology of fludarabine.

Gandhi V, Plunkett W. Gandhi V, et al. Among authors: plunkett w. Clin Pharmacokinet. 2002;41(2):93-103. doi: 10.2165/00003088-200241020-00002. Clin Pharmacokinet. 2002. PMID: 11888330 Review.

5

The role of clofarabine in hematologic and solid malignancies--development of a next-generation nucleoside analog.

Faderl S, Gandhi V, Keating MJ, Jeha S, Plunkett W, Kantarjian HM. Faderl S, et al. Among authors: plunkett w. Cancer. 2005 May 15;103(10):1985-95. doi: 10.1002/cncr.21005. Cancer. 2005. PMID: 15803490 Free article. Review.

6

A randomized phase 2 study of idarubicin and cytarabine with clofarabine or fludarabine in patients with newly diagnosed acute myeloid leukemia.

Jabbour E, Short NJ, Ravandi F, Huang X, Xiao L, Garcia-Manero G, Plunkett W, Gandhi V, Sasaki K, Pemmaraju N, Daver NG, Borthakur G, Jain N, Konopleva M, Estrov Z, Kadia TM, Wierda WG, DiNardo CD, Brandt M, O'Brien SM, Cortes JE, Kantarjian H. Jabbour E, et al. Among authors: plunkett w. Cancer. 2017 Nov 15;123(22):4430-4439. doi: 10.1002/cncr.30883. Epub 2017 Jul 14. Cancer. 2017. PMID: 28708931 Free PMC article. Clinical Trial.

7

Inhibition of fludarabine metabolism by arabinosylcytosine during therapy.

Kemena A, Gandhi V, Shewach DS, Keating M, Plunkett W. Kemena A, et al. Among authors: plunkett w. Cancer Chemother Pharmacol. 1992;31(3):193-9. doi: 10.1007/BF00685547. Cancer Chemother Pharmacol. 1992. PMID: 1464155 Free article.

8

Metabolism and action of fludarabine phosphate.

Plunkett W, Huang P, Gandhi V. Plunkett W, et al. Semin Oncol. 1990 Oct;17(5 Suppl 8):3-17. Semin Oncol. 1990. PMID: 1699280 Review.

9

Fludarabine infusion potentiates arabinosylcytosine metabolism in lymphocytes of patients with chronic lymphocytic leukemia.

Gandhi V, Kemena A, Keating MJ, Plunkett W. Gandhi V, et al. Among authors: plunkett w. Cancer Res. 1992 Feb 15;52(4):897-903. Cancer Res. 1992. PMID: 1737352

10

Modulatory activity of 2',2'-difluorodeoxycytidine on the phosphorylation and cytotoxicity of arabinosyl nucleosides.

Gandhi V, Plunkett W. Gandhi V, et al. Among authors: plunkett w. Cancer Res. 1990 Jun 15;50(12):3675-80. Cancer Res. 1990. PMID: 2340517

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

320 results

Search Page